Anzeige
Mehr »
Donnerstag, 04.09.2025 - Börsentäglich über 12.000 News
Geheime Uran-Aktie: Ist das der historische "New Deal"-Moment für amerikanischen Uransektor?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: SHL100 | ISIN: DE000SHL1006 | Ticker-Symbol: SHL
Xetra
03.09.25 | 17:35
46,660 Euro
+0,86 % +0,400
1-Jahres-Chart
SIEMENS HEALTHINEERS AG Chart 1 Jahr
5-Tage-Chart
SIEMENS HEALTHINEERS AG 5-Tage-Chart
RealtimeGeldBriefZeit
46,41046,83003.09.
46,40046,85003.09.
GlobeNewswire (Europe)
281 Leser
Artikel bewerten:
(1)

Evident: EVIDENT and Siemens Healthineers Join Efforts to Advance Digital Pathology at Klinikum Ludwigshafen

Collaboration combines AI imaging, diagnostics expertise, and clinical leadership to drive digital pathology forward

WALTHAM, Mass. and ERLANGEN, Germany and LUDWIGSHAFEN, Germany, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Siemens Healthineers, a leading global medical technology company, and Evident - which recently acquired Pramana, an AI-enabled health tech company modernizing the pathology sector - announced a strategic alliance to deliver a fully digital pathology workflow to Klinikum der Stadt Ludwigshafen am Rhein in Germany. This initiative will help expand access to advanced diagnostics, streamline processes, and support improved patient care.

"By combining Evident's innovative approach for advanced imaging precision with our digital pathology solutions, we can integrate seamlessly into clinical workflows. This helps pathologists to diagnose with greater confidence while patients benefit from faster, more accurate treatment decisions," said Svenja Lippok, Head of Digital Pathology & Cardiology IT at Siemens Healthineers.

"For us, digital pathology is not about efficiency gains - it is a pivotal step in our journey to deliver truly personalized healthcare," said Dr. Mindaugas Andrulis, Head of the Institute of Pathology at Klinikum Ludwigshafen. "Together with Evident and Siemens Healthineers, we are not merely deploying an advanced digital pathology solution in isolation. We are integrating pathology with other diagnostic disciplines into a unified IT framework - the foundation of a data-driven hospital and, ultimately, an operating system that transforms AI models into real clinical care."

Klinikum Ludwigshafen is a major non-profit teaching hospital and regional diagnostic hub serving the Rhine-Neckar metropolitan area, with a high-volume pathology lab that handles more than 25,000 histological cases annually. This integrated solution will support the hospital's centralized digital pathology workflows and enable scanning of multiple specimen types, including cytology, using advanced volumetric imaging. The clinical and technological expertise of Siemens Healthineers, combined with Evident's Pramana CE-IVDR-certified digital pathology platform, which features scanning automation, inline AI readiness, and integrated quality assurance and quality control, will deliver streamlined diagnostics and greater accuracy to support clinical decision-making.

"Digitizing pathology is more than just modernizing infrastructure-it's about creating a foundation for faster diagnoses, stronger clinical collaboration, and smarter AI integration," said Prasanth Perugupalli, Vice President and General Manager of Digital Pathology at Evident. "Together with Siemens Healthineers, we're helping pathology labs and hospitals like Klinikum Ludwigshafen confidently take the next step toward scalable, next-generation testing capabilities."

Siemens Healthineers and Klinikum Ludwigshafen will share early learnings and operational insights from the deployment during a speaking session on September 7 from 1:00 to 2:30 PM CEST, titled "The Path Forward - Navigating the Digital Transformation in Pathology," at the European Congress of Pathology (ECP), September 6-10 in Vienna, Austria. Visit Evident at booth #17, Pramana at booth #108, and Siemens Healthineers at booth #88, for more information.

About EVIDENT
For over 100 years as Olympus, we set the industry standard for optical precision in microscopy, helping the world see what was once out of view. Today, as Evident, we continue to help scientists, physicians, and engineers illuminate the unseen with advanced imaging solutions that combine renowned optics with cutting-edge digital innovation.

Our life science portfolio supports research, clinical diagnostics, and education, offering a comprehensive range of imaging methods from essential brightfield and darkfield microscopy to advanced fluorescence, 4D analysis, and digital pathology. In industrial microscopy, we deliver precision and flexibility through laser scanning, digital, and semiconductor microscopes designed for tasks ranging from routine inspection to intricate quality control and manufacturing analysis.

Whether advancing new therapies, ensuring product integrity, or exploring the unknown, Evident is defining a new era of discovery with easy-to-use tools that help unlock hidden answers and empower exciting new breakthroughs.

Evident is headquartered in Tokyo and supported by R&D and manufacturing centers in Japan, the United States, Germany, and China, with operations and dedicated sales and service centers around the world. For more information, visit EvidentScientific.com/solutions/digital-pathology.



Media Contacts Evident: Michelle Gaynor michelle.gaynor.ext@evidentscientific.com Siemens Healthineers: Kathrin Palder, Press Officer kathrin.palder@siemens-healthineers.com Klinikum Ludwigshafen: Annette Weber webera@klilu.de

© 2025 GlobeNewswire (Europe)
Solarbranche vor dem Mega-Comeback?
Lange galten Solaraktien als Liebling der Börse, dann kam der herbe Absturz: Zinsschock, Überkapazitäten aus China und ein Preisverfall, der selbst Marktführer wie SMA Solar, Enphase Energy oder SolarEdge massiv unter Druck setzte. Viele Anleger haben der Branche längst den Rücken gekehrt.

Doch genau das könnte jetzt die Chance sein!
Die Kombination aus KI-Explosion und Energiewende bringt die Branche zurück ins Rampenlicht:
  • Rechenzentren verschlingen Megawatt – Solarstrom bietet den günstigsten Preis je Kilowattstunde
  • Moderne Module liefern Wirkungsgrade wie Atomkraftwerke
  • hina bremst Preisdumping & pusht massiv den Ausbau
Gleichzeitig locken viele Solar-Aktien mit historischen Tiefstständen und massiven Short-Quoten, ein perfekter Nährboden für Kursrebound und Squeeze-Rally.

In unserem exklusiven Gratis-Report zeigen wir dir, welche 4 Solar-Aktien besonders vom Comeback profitieren dürften und warum jetzt der perfekte Zeitpunkt für einen Einstieg sein könnte.

Laden Sie jetzt den Spezialreport kostenlos herunter, bevor die Erholung am Markt beginnt!

Dieses Angebot gilt nur für kurze Zeit – also nicht zögern, jetzt sichern!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.